AKT1 and cancer: Recent studies have shown that treatment with EPA-, DHA- or Se-containing compounds decreases the phosphorylation of AKT (Ser473, not Thr308) and decreases PI3K activity in cancer cell lines and tumor-bearing mice [12,31,32].